CD3D silencing alleviates diabetic nephropathy via inhibition of JAK / STAT pathway
- 12 November 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (21) , e70169
Abstract
Diabetic nephropathy (DN) is a severe microvascular complication of diabetes that poses a significant burden to global health. This investigation aims to illustrate the functional role of CD3D and its relevant mechanisms in DN progression. The pivotal genes between the GSE47183 and GSE30528 datasets were identified using bioinformatics methods. The effects of CD3D silencing on renal damage, inflammatory response, and lipid metabolism were validated in DN mice. Furthermore, the impacts of CD3D knockdown on cell viability, apoptotic rate, inflammation, and lipid levels were investigated in HK‐2 cells under high glucose (HG) conditions. Additionally, RO8191 was employed to investigate the role of CD3D in the JAK/STAT pathway in HG‐treated cells. A total of 5 focal genes were identified through bioinformatics and were found to be upregulated in renal tissues from DN mice. CD3D silencing mitigated pathological damage to kidneys, reduced inflammatory response, and decreased lipid accumulation in DN mice. HG stimulation restrained viability, increased apoptosis, promoted the release of inflammatory cytokines, and affected expressions of hallmarks related to lipid metabolism in HG‐treated cells; these changes were partially abolished by CD3D knockdown. Mechanistically, CD3D downregulation ameliorated HG‐induced injury in HK‐2 cells by blocking the JAK/STAT pathway. This study underscores that CD3D silencing has significant potential as a promising candidate in the treatment of DN.Keywords
Funding Information
- National Natural Science Foundation of China (82160136)
This publication has 40 references indexed in Scilit:
- Melatonin attenuates cellular senescence and apoptosis in diabetic nephropathy by regulating STAT3 phosphorylationLife Sciences, 2023
- The role of innate immunity in diabetic nephropathy and their therapeutic consequencesJournal of Pharmaceutical Analysis, 2023
- SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathyDrug Discovery Today, 2023
- Hederagenin ameliorates renal fibrosis in chronic kidney disease through blocking ISG15 regulated JAK/STAT signalingInternational Immunopharmacology, 2023
- Signaling pathways of chronic kidney diseases, implications for therapeuticsSignal Transduction and Targeted Therapy, 2022
- MiR-145 participates in the development of lupus nephritis by targeting CSF1 to regulate the JAK/STAT signaling pathwayCytokine, 2022
- JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytesEuropean Journal of Pharmacology, 2021
- Interference of S100A16 suppresses lipid accumulation and inflammation in high glucose-induced HK-2 cellsInternational Urology and Nephrology, 2021
- TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathyInflammation Research, 2020
- Interference with miR-210 Alleviated Renal Injury in Septic Rats by Inhibiting JAK-STAT PathwayInflammation, 2020